| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.3 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |